BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22343053)

  • 1. Tumor-mast cell interactions: induction of pro-tumorigenic genes and anti-tumorigenic 4-1BB in MCs in response to Lewis Lung Carcinoma.
    Wensman H; Kamgari N; Johansson A; Grujic M; Calounova G; Lundequist A; Rönnberg E; Pejler G
    Mol Immunol; 2012 Apr; 50(4):210-9. PubMed ID: 22343053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of GADD-45alpha and VEGF induced tumor recurrence via upregulation of IL-2 after photodynamic therapy using NPe6.
    Ohtani K; Usuda J; Ichinose S; Ishizumi T; Hirata T; Inoue T; Maehara S; Imai K; Kubota M; Tsunoda Y; Yamada M; Tsutsui H; Yamada K; Kuroiwa Y; Furukawa K; Okunaka T; Kato H
    Int J Oncol; 2008 Feb; 32(2):397-403. PubMed ID: 18202762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the chemokine receptor CCR6 in the Lewis lung carcinoma (LLC) cell line reduces its metastatic potential in vivo.
    Sutherland A; Mirjolet JF; Maho A; Parmentier M
    Cancer Gene Ther; 2007 Oct; 14(10):847-57. PubMed ID: 17599091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphoglycerate kinase 1-overexpressing lung cancer cells reduce cyclooxygenase 2 expression and promote anti-tumor immunity in vivo.
    Tang SJ; Ho MY; Cho HC; Lin YC; Sun GH; Chi KH; Wang YS; Jhou RS; Yang W; Sun KH
    Int J Cancer; 2008 Dec; 123(12):2840-8. PubMed ID: 18814280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential gene expression profile between cord blood progenitor-derived and adult progenitor-derived human mast cells.
    Inomata N; Tomita H; Ikezawa Z; Saito H
    Immunol Lett; 2005 May; 98(2):265-71. PubMed ID: 15860227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions.
    Stelekati E; Bahri R; D'Orlando O; Orinska Z; Mittrücker HW; Langenhaun R; Glatzel M; Bollinger A; Paus R; Bulfone-Paus S
    Immunity; 2009 Oct; 31(4):665-76. PubMed ID: 19818652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternatively activated RAW264.7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma.
    Zhang B; Wang J; Gao J; Guo Y; Chen X; Wang B; Gao J; Rao Z; Chen Z
    J Cell Biochem; 2009 May; 107(1):134-43. PubMed ID: 19241443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor alpha promotes the expression of stem cell factor in synovial fibroblasts and their capacity to induce mast cell chemotaxis.
    Kiener HP; Hofbauer R; Tohidast-Akrad M; Walchshofer S; Redlich K; Bitzan P; Kapiotis S; Steiner G; Smolen JS; Valent P
    Arthritis Rheum; 2000 Jan; 43(1):164-74. PubMed ID: 10643713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FcepsilonRI-mediated amphiregulin production by human mast cells increases mucin gene expression in epithelial cells.
    Okumura S; Sagara H; Fukuda T; Saito H; Okayama Y
    J Allergy Clin Immunol; 2005 Feb; 115(2):272-9. PubMed ID: 15696081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
    Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
    Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor binding protein-4 (IGFBP-4) is a novel anti-angiogenic and anti-tumorigenic mediator secreted by dibutyryl cyclic AMP (dB-cAMP)-differentiated glioblastoma cells.
    Moreno MJ; Ball M; Andrade MF; McDermid A; Stanimirovic DB
    Glia; 2006 Jun; 53(8):845-57. PubMed ID: 16586492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer.
    Chen JJ; Yao PL; Yuan A; Hong TM; Shun CT; Kuo ML; Lee YC; Yang PC
    Clin Cancer Res; 2003 Feb; 9(2):729-37. PubMed ID: 12576442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and application of three novel monoclonal antibodies against human 4-1BB: distinct epitopes of human 4-1BB on lung tumor cells and immune cells.
    Zhang GB; Dong QM; Hou JQ; Ge Y; Ju SG; Lu BF; Zhang XG
    Tissue Antigens; 2007 Dec; 70(6):470-9. PubMed ID: 17990986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinoxaline 1,4-dioxides are novel angiogenesis inhibitors that potentiate antitumor effects of ionizing radiation.
    Gali-Muhtasib H; Sidani M; Geara F; Mona AD; Al-Hmaira J; Haddadin MJ; Zaatari G
    Int J Oncol; 2004 May; 24(5):1121-31. PubMed ID: 15067333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor resistance to anti-VEGF therapy through up-regulation of VEGF-C expression.
    Li D; Xie K; Ding G; Li J; Chen K; Li H; Qian J; Jiang C; Fang J
    Cancer Lett; 2014 Apr; 346(1):45-52. PubMed ID: 24333721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bee venom inhibits tumor angiogenesis and metastasis by inhibiting tyrosine phosphorylation of VEGFR-2 in LLC-tumor-bearing mice.
    Huh JE; Baek YH; Lee MH; Choi DY; Park DS; Lee JD
    Cancer Lett; 2010 Jun; 292(1):98-110. PubMed ID: 20188461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation.
    Yap LF; Jenei V; Robinson CM; Moutasim K; Benn TM; Threadgold SP; Lopes V; Wei W; Thomas GJ; Paterson IC
    Oncogene; 2009 Jul; 28(27):2524-34. PubMed ID: 19448673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of human mast cells through the platelet-activating factor receptor.
    Kajiwara N; Sasaki T; Bradding P; Cruse G; Sagara H; Ohmori K; Saito H; Ra C; Okayama Y
    J Allergy Clin Immunol; 2010 May; 125(5):1137-1145.e6. PubMed ID: 20392487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmalemmal vesicle associated protein-1 is a novel marker implicated in brain tumor angiogenesis.
    Carson-Walter EB; Hampton J; Shue E; Geynisman DM; Pillai PK; Sathanoori R; Madden SL; Hamilton RL; Walter KA
    Clin Cancer Res; 2005 Nov; 11(21):7643-50. PubMed ID: 16278383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omalizumab inhibits acceleration of FcεRI-mediated responsiveness of immature human mast cells by immunoglobulin E.
    Okayama Y; Kashiwakura J; Sasaki-Sakamoto T; Matsumoto K; Hashimoto N; Ohmori K; Kawakami T; Saito H; Ra C
    Ann Allergy Asthma Immunol; 2012 Mar; 108(3):188-94. PubMed ID: 22374203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.